Use of Recombinant Human Bone Morphogenetic Protein-2 at the C1-C2 Lateral Articulation without Posterior Structural Bone Graft in Posterior Atlantoaxial Fusion in Adult Patients.

MLA

Ishida, Wataru, et al. “Use of Recombinant Human Bone Morphogenetic Protein-2 at the C1-C2 Lateral Articulation without Posterior Structural Bone Graft in Posterior Atlantoaxial Fusion in Adult Patients.” World Neurosurgery, vol. 123, Mar. 2019, pp. e69–76. EBSCOhost, https://doi.org/10.1016/j.wneu.2018.11.037.

APA

Ishida, W., Ramhmdani, S., Xia, Y., Kosztowski, T. A., Xu, R., Choi, J., De la Garza Ramos, R., Elder, B. D., Theodore, N., Gokaslan, Z. L., Sciubba, D. M., Witham, T. F., Bydon, A., Wolinsky, J.-P., & Lo, S.-F. L. (2019). Use of Recombinant Human Bone Morphogenetic Protein-2 at the C1-C2 Lateral Articulation without Posterior Structural Bone Graft in Posterior Atlantoaxial Fusion in Adult Patients. World Neurosurgery, 123, e69–e76. https://doi.org/10.1016/j.wneu.2018.11.037

Chicago

Ishida, Wataru, Seba Ramhmdani, Yuanxuan Xia, Thomas A. Kosztowski, Risheng Xu, John Choi, Rafael De la Garza Ramos, et al. 2019. “Use of Recombinant Human Bone Morphogenetic Protein-2 at the C1-C2 Lateral Articulation without Posterior Structural Bone Graft in Posterior Atlantoaxial Fusion in Adult Patients.” World Neurosurgery 123 (March): e69–76. doi:10.1016/j.wneu.2018.11.037.